Constitutively active mutant versions of receptor tyrosine kinases (RTKs), e.g. EGFR (EGFRvIII), PDGFRA or MET (METΔ7–8 [11]), are commonly encountered in primary glioblastomas [12]. This evidence concerns the gene EGFR and glioblastoma.